Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dermatix gel
20031400015
|
Dermatix gel | Wound Management & Other Dressings | Dressings | 1,163 |
|
Levemir InnoLet 100units/ml inj 3ml pre-filled pens
0601012X0BBACAB
|
Insulin Levemir (Novo-Nordisk) | Insulin detemir | Endocrine System | 1,162 |
|
OpSite Post-Op dressing 8.5cm x 9.5cm
20030100550
|
OpSite Post-Op dressing 8.5cm x 9.5cm | Wound Management & Other Dressings | Dressings | 1,162 |
|
Careline sterile leg bag with lever tap long tube 500ml
22505055007
|
Careline sterile leg bag with lever tap long tube 500ml | Leg Bags | Incontinence Appliances | 1,161 |
|
Ibuleve Maximum Strength 10% gel
1003020P0BCAFAI
|
Ibuleve | Ibuprofen | Musculoskeletal and Joint Diseases | 1,161 |
|
Codipar 15mg/500mg capsules
0407010F0BVABAV
|
Codipar | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | 1,160 |
|
Verapress MR 240mg tablets (Dexcel-Pharma)
0206020T0BHAAAH
|
Verapress | Verapamil hydrochloride | Cardiovascular System | 1,160 |
|
Coban 2 Lite multi-layer compression bandage kit
20020201074
|
Coban 2 Lite multi-layer compression bandage kit | Arm Sling/Bandages | Dressings | 1,159 |
|
Moclobemide 300mg tablets
0403020K0AAACAC
|
Moclobemide | Moclobemide | Central Nervous System | 1,159 |
|
Nova 2 two piece ostomy system convex 55mm flange 15-42mm
23940709662
|
Nova 2 two piece ostomy system convex 55mm flange 15-42mm | Two Piece Ostomy Systems | Stoma Appliances | 1,158 |
|
Calcium acetate 435mg / Magnesium carbonate heavy 235mg tab
0905022U0AAAAAA
|
Calcium acetate/magnesium carbonate heavy | Calcium acetate/magnesium carbonate | Nutrition and Blood | 1,157 |
|
Misoprostol 200microgram tablets
0103040M0AAAAAA
|
Misoprostol | Misoprostol | Gastro-Intestinal System | 1,157 |
|
Duocal Super Soluble powder
0913142B0BCAAAB
|
Duocal pdr 3.8 - 4.9 kcal/g energy (carbohyd) fortifier | Pdr 3.8 - 4.9 kcal/g energy (carbohyd) fortifier (0913142) | Nutrition and Blood | 1,156 |
|
Mepilex Border Lite dressing 7.5cm x 7.5cm
20030900046
|
Mepilex Border Lite dressing 7.5cm x 7.5cm | Wound Management & Other Dressings | Dressings | 1,155 |
|
Tegaderm Foam dressing (adhesive) 19cm x 22.2cm oval
20030600343
|
Tegaderm Foam dressing (adhesive) 19cm x 22.2cm oval | Wound Management & Other Dressings | Dressings | 1,155 |
|
Amoxicillin 3g oral powder sachets sugar free
0501013B0AAAHAH
|
Amoxicillin | Amoxicillin | Infections | 1,154 |
|
Ationdo SR 50mg tablets
0407020AGBCABAC
|
Ationdo | Tapentadol | Central Nervous System | 1,154 |
|
Glyceryl trinitrate 300microgram sublingual tablets
0206010F0AAA5A5
|
Glyceryl trinitrate (Angina) | Glyceryl trinitrate | Cardiovascular System | 1,154 |
|
UrgoStart plus Pad dressing 10cm x 10cm square
20031700275
|
UrgoStart plus Pad dressing 10cm x 10cm square | Wound Management & Other Dressings | Dressings | 1,154 |
|
Clobetasol 500microg/Neomycin 5mg/Nystatin 100,000u/g oint
1304000G0AACBCB
|
Clobetasol propionate | Clobetasol propionate | Skin | 1,153 |
|
Haddenham EasyWrap Strong (30-40mmHg) leg
21270002374
|
Haddenham EasyWrap Strong (30-40mmHg) leg | Lymphoedema Garments | Appliances | 1,153 |
|
Medomon XL 60mg tablets
0206010K0CVAAAE
|
Medomon XL | Isosorbide mononitrate | Cardiovascular System | 1,153 |
|
Naproxen 250mg/5ml oral suspension
1001010P0AABFBF
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 1,153 |
|
Oxycodone 20mg/2ml solution for injection ampoules
0407020ADAAAMAM
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 1,153 |
|
Dandrazol 2% shampoo
1309000I0BEAAAA
|
Dandrazol | Ketoconazole | Skin | 1,151 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.